SCHEMBL8986207

SCHEMBL8986207

CNC/C=C/c1ccccc1OCCN

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
HTR1B P28222 3/20 0.46
HPGD P15428 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
PTGER3 P43115 1/20 0.41
ALDH1A1 P00352 3/20 0.40
HTR1D P28221 1/20 0.40
HTT P42858 1/20 0.40
NFE2L2 Q16236 2/20 0.39
SLC6A4 P31645 2/20 0.39
HRH1 P35367 1/20 0.39
TAAR1 Q96RJ0 1/20 0.38
TSHR P16473 1/20 0.37
LTA4H P09960 1/20 0.36
CDK4 P11802 2/20 0.36
CCND1 P24385 2/20 0.36
CCNB2 O95067 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12377073 0.86 AR (0.42) KDM4EHTR1BHPGDSMN1; SMN2RAB9A
SCHEMBL13091453 0.78 KDM4E (0.59) KDM4EHTR1BHPGDSMN1; SMN2TP53
SCHEMBL10475475 0.74 SLC6A2 (0.43) KDM4EHPGDALDH1A1NFE2L2SLC6A4
SCHEMBL11192818 0.73 NFE2L2 (0.58) KDM4EHTR1BHPGDSMN1; SMN2TP53
SCHEMBL11192822 0.73 NFE2L2 (0.58) KDM4EHTR1BHPGDSMN1; SMN2TP53
SCHEMBL8986209 0.73 APP (0.47) TAAR1LTA4H
SCHEMBL10362247 0.72 GAA (0.46) SMN1; SMN2PTGER3ALDH1A1HTTSLC6A4
SCHEMBL8986180 0.72 TLR4 (0.43) KDM4ESMN1; SMN2RAB9AALDH1A1NFE2L2
SCHEMBL31050988 0.71 KDM4E (0.95) KDM4EHTR1BHPGDSMN1; SMN2TP53
SCHEMBL8834938 0.71 KDM4E (0.95) KDM4EHTR1BHPGDSMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188216-B2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery TRANZYME PHARMA INC. (CA) 2012-05-29 US disclosed
US-7169899-B1 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents TRANZYME PHARMA INC. (CA) 2007-01-30 US disclosed